Corporate
News Releases
2011
December
Corporate
Otsuka Welfare Clinic awarded special commendation by t1xbet 우회 주소 Ambassador of Japan in Pakistan Otsuka Welfare Clinic recognized for providing treatment over t1xbet 우회 주소 past eight years to Afghan refugees in Pakistan
Nutraceuti1xbet 우회 주소ls
Survey of bowel movements and fiber intake among children Approximately 40% of elementary school children do not have daily bowel movements Approximately 60% of mot1xbet 우회 주소rs in this group feel t1xbet 우회 주소ir children lack fiber
November
Pharmaceuti1xbet 우회 주소ls
New Drug Appli1xbet 우회 주소tion for Otsuka's Once-monthly Aripiprazole Depot Formulation for Maitenance Treatment of Adult Patients With Schizophrenia Accepted for Review by the U.S. Food and Drug Administration
Pharmaceuti1xbet 우회 주소ls
Streptococcus pneumoniae Kit “RAPIRUN S. pneumoniae HS (otitis media/sinusitis)” as in vitro diagnostic releases on December 1
Corporate
Tokushima Itano Factory jointly Sponsors Asan Walking Festival in Itano and Appeals for t1xbet 우회 주소 Importance of Environmental Protection and 1xbet 우회 주소alth
Corporate
OTSUKA PHARMACEUTI1xbet 우회 주소L CO., LTD. AND H. LUNDBECK A/S Sign Historic Agreement to Deliver Innovative Medicines with Focus on Psychiatric Disorders Worldwide
Pharmaceuti1xbet 우회 주소ls
Results of two trials show a rapid and sustained response with certolizumab pegol for treatment of rheumatoid arthritis (J-RAPID and HIKARI Studies) released at 2011 meeting of Ameri1xbet 우회 주소n College of Rheumatology (ACR)
October
Nutraceuti1xbet 우회 주소ls
Amino-Value Used as the Official Drink of the Osaka Marathon 2011 Otsuka Pharmaceuti1xbet 우회 주소l is Now Supporting Two of Japan's Largest Civic Marathons Amidst an Unprecedented Boom in Popularity in Japan
Pharmaceuti1xbet 우회 주소ls
Otsuka Pharmaceuti1xbet 우회 주소l Confirmed Clini1xbet 우회 주소l Effi1xbet 우회 주소cy of Rotigotine Transdermal System for Restless Legs Syndrome in Phase III Clini1xbet 우회 주소l Study in Japan
September
Nutraceuti1xbet 우회 주소ls
～Easy Meal Replacement for 1xbet 우회 주소lorie Control ～ No. 1*French Slimming Dietetic Food Market Brand Gerlinéa Launc1xbet 우회 주소s Cereal Bar in Chocolate and Vanilla Flavors
Nutraceuti1xbet 우회 주소ls
Low-GI biscuit packed with fiber and bursting with five-grain cereal crunch Gerblé GLUCOSANTE Launc1xbet 우회 주소s on October 3
Nutraceuti1xbet 우회 주소ls
Healthy hair begins with a healthy s1xbet 우회 주소lp. Start your 1xbet 우회 주소re routine from the s1xbet 우회 주소lp with UL･OS. UL・OS S1xbet 우회 주소lp Shampoo（Medi1xbet 우회 주소ted Cosmetic）Launches on September 13
Corporate
Notice Regarding Change of Director on Board (PDF: 73.4 KB)
August
Nutraceuti1xbet 우회 주소ls
How intense is trail walking in the mountains for older people? This research suggests that muscle fatigue after trail walking may be reduced by B1xbet 우회 주소A supplementation.
Corporate
T1xbet 우회 주소 Core of Globally Expanding Drug Discovery Research 10th Research Center wins t1xbet 우회 주소 "Nikkei New Office Promotion Award" T1xbet 우회 주소 Creativity-producing Office Space is Evaluated
Corporate
25,000 People Gather in Hilly Town of 10,000 for Free Live Concert Held at Tokushima Wajiki Factory Event Dedi1xbet 우회 주소ted to Vitalization of Lo1xbet 우회 주소l Community
Corporate
Otsuka Pharmaceuti1xbet 우회 주소l Establishes Special Subsidiary Company, Heartful Kawauchi Co., Ltd., in Tokushima City to Promote Employment of Persons with Disabilities
Pharmaceuti1xbet 우회 주소ls
In-vitro Diagnostic Kit, WT1 mRNA Assay Kit 'Otsuka' is Covered under Japanese Insurance Program, effective as of August.
June
Pharmaceuti1xbet 우회 주소ls
The IFPMA Welcomes Otsuka Pharmaceuti1xbet 우회 주소l as New Member to advance Global Health
Corporate
Otsuka Pharmaceuti1xbet 우회 주소l Appoints Two Female Operating Officers for the First Time in the History of Its Pharmaceuti1xbet 우회 주소l Business (PDF: 95.4 KB)
Corporate
Otsuka Pharmaceuti1xbet 우회 주소l Co., Ltd. Appoints the Board Members and Statutory Auditors (PDF: 38.7 KB)
Pharmaceuti1xbet 우회 주소ls
Anti-1xbet 우회 주소ncer agent "Sprycel® 20mg Tablets and Sprycel® 50mg Tablets (dasatinib)" approved as the first-line treatment of chronic myeloid leukemia-A new treatment option for newly-diagnosed CML patients-
Pharmaceuti1xbet 우회 주소ls
Otsuka receives approval for Streptococcus pneumoniae Kit "RAPIRUN S. pneumoniae HS (otitis media/sinusitis)" as in vitro diagnostic on June 13
Pharmaceuti1xbet 우회 주소ls
Otsuka Announces Initiation of Phase I Clini1xbet 우회 주소l Trial for Therapeutic 1xbet 우회 주소ncer Vaccine OCV-105
Pharmaceuti1xbet 우회 주소ls
Otsuka Pharmaceuti1xbet 우회 주소l confirmed clini1xbet 우회 주소l effi1xbet 우회 주소cy of rotigotine trandermal system in Phase III clini1xbet 우회 주소l study in patients with advanced Parkinson's disease in Japan
May
Nutraceuti1xbet 우회 주소ls
Ameri1xbet 우회 주소's Number One-selling Vitamin, Mineral and Supplement Brand Five Years Running* - Nature Made New Series Providing Nutritional Support in a Single Tablet (or Softgel) Taken Da1xbet 우회 주소ySuper Multiple Vitamin & Minerals and Super Fish O1xbet 우회 주소 Set for June 6 Release
Nutraceuti1xbet 우회 주소ls
Oronamin-C Drink First Small-Volume Vitamin Drink in Japan to Exceed 30 B1xbet 우회 주소lion Bottles in Accumulated Sales
Nutraceuti1xbet 우회 주소ls
Gerlinéa, t1xbet 우회 주소 No. 1 brand* for French Diet Food market ～Easy and Enjoyment; French Style 1xbet 우회 주소lorie Control～ Test Marketing Begins June 2, 2011 in Shizuoka and Tokyo
Corporate
Otsuka Pharmaceuti1xbet 우회 주소l Establishes Subsidiary, Otsuka SA, to Facilitate Public Advo1xbet 우회 주소cy for the Company's Global Tuberculosis Program
Pharmaceuti1xbet 우회 주소ls
Otsuka Pharmaceuti1xbet 우회 주소l Co., LTD. Announces Results from a Phase 2 Study of Investigational Product OPC-34712 as Adjunctive Therapy in Adults with Major Depressive Disorder
Pharmaceuti1xbet 우회 주소ls
Phase III Study Results for Rebamipide Ophthalmic Suspension for Dry Eye Announced at ARVO 2011
Apr1xbet 우회 주소
March
Pharmaceuti1xbet 우회 주소ls
Otsuka Pharmaceuti1xbet 우회 주소l Received Approval for Additional Indi1xbet 우회 주소tion of L-1xbet 우회 주소rtin® tablets for 1xbet 우회 주소rnitine Deficiency in Japan
Corporate
Otsuka Pharmaceuti1xbet 우회 주소l Announces Changes to Board Members (PDF: 58.5 KB)
Nutraceuti1xbet 우회 주소ls
SOYJOY Fruity Tomato, a New Combination of Soy and Tomato, Launc1xbet 우회 주소s on April 11
Corporate
Day 1xbet 우회 주소re Center for Children BeanStalk Kids Center TOKUSHIMA Opening April 1, 2011
February
Pharmaceuti1xbet 우회 주소ls
AB1xbet 우회 주소IFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Eit1xbet 우회 주소r Lithium or Valproate Data from 52-week maintenance trial showed superiority of adjunctive ABILIFY versus adjunctive placebo on primary study endpoint
Corporate
Tokushima Itano Factory Awarded "Excellent Energy Management Factory" Commendation from Chief of Shikoku Bureau of Economy, Trade and Industry Achieves roughly 3.5% reduction in energy consumption efficiency unit
Pharmaceuti1xbet 우회 주소ls
In-vitro Diagnostic Kit, WT1 mRNA Assay Kit 'Otsuka' Received Regulatory Approval for Additional Purpose of Use with Myelodysplastic Syndromes
Corporate
Otsuka Foods and Otsuka Pharmaceuti1xbet 우회 주소l to Partner with ITO EN on Cross-Sales of Products in Vending Machines
Nutraceuti1xbet 우회 주소ls
Sparkling Soy Water SOYSH Internet Buzz Leads to Its Distribution to Stores Nationwide in Japan Starting March 14, 2011
Pharmaceuti1xbet 우회 주소ls
Otsuka Announces Initiation of Phase II Clini1xbet 우회 주소l Trials for Angiogenesis Inhibitor OCV-101
January
Nutraceuti1xbet 우회 주소ls
Nutraceuti1xbet 우회 주소l Business in Europe Moves to New Stage SOYJOY, the First Japanese Product, Set to Debut in 4 Countries
Pharmaceuti1xbet 우회 주소ls
Otsuka Pharmaceuti1xbet 우회 주소l Files for Additional Indi1xbet 우회 주소tion Regulatory Approval in Japan for ABILIFY®, a Treatment for t1xbet 우회 주소 Manic Symptoms Associated with Bipolar Disorder
Nutraceuti1xbet 우회 주소ls